Study of the Acute Effects of Triheptanoin in Heart Failure

Summary

Patients with dilated cardiomyopathy who present for indwelling right heart catheterization will be enrolled and randomized to either control or triheptanoin oil for five days. Hemodynamics will be assess serially.

Timeline

Start

2013-02

Primary completion

2014-02

Completion

2014-02

Outcome

Outcome not reported

Stopped (Enrollment): “eIRB closed, no patient enrolled”

Drugs

Indications